| 1. Douglas A. Levine, Richard R. Barakat, Nadeem R. Abu-Rustum, 2008. Atlas of Procedures in Gynecologic Oncology, Second Edition. Informa HealthCare, London, UK. 320 pp. Hardbound, ISBN: 978-0-418-21732-0. |
Page:281—281 |
| 2. In reply. |
Page:280—280 |
| 3. In reply. |
Page:280—280 |
| 4. Clinical significance of postoperative CA-125 level after primary cytoreductive surgery in ovarian cancer. |
Page:279—279 |
| 5. Clinical significance of postoperative CA-125 level after primary cytoreductive surgery in ovarian cancer. |
Page:279—279 |
| 6. An ovarian mucinous cystadenocarcinoma arising from mature cystic teratoma with para-aortic lymph node metastasis: a case report. |
Page:275—278 |
| 7. An ovarian mucinous cystadenocarcinoma arising from mature cystic teratoma with para-aortic lymph node metastasis: a case report. |
Page:275—278 |
| 8. A case of huge sclerosing stromal tumor of the ovary weighing 10 kg in a 71-year-old postmenopausal woman. |
Page:270—274 |
| 9. A case of huge sclerosing stromal tumor of the ovary weighing 10 kg in a 71-year-old postmenopausal woman. |
Page:270—274 |
| 10. A case report of quadruple cancer in a single patient including the breast, rectum, ovary, and endometrium. |
Page:265—269 |
| 11. A case report of quadruple cancer in a single patient including the breast, rectum, ovary, and endometrium. |
Page:265—269 |
| 12. Leiomyosarcoma of the vagina: a case report and review from the literature. |
Page:261—264 |
| 13. Leiomyosarcoma of the vagina: a case report and review from the literature. |
Page:261—264 |
| 14. The effect of adjuvant hormonal therapy on the endometrium and ovary of breast cancer patients. |
Page:256—260 |
| 15. The effect of adjuvant hormonal therapy on the endometrium and ovary of breast cancer patients. |
Page:256—260 |
| 16. Comparison between L and E gene amplification analytical methods for human papillomavirus typing. |
Page:251—255 |
| 17. Comparison between L and E gene amplification analytical methods for human papillomavirus typing. |
Page:251—255 |
| 18. Comparison of modified Cherney incision and vertical midline incision for management of early stage cervical cancer. |
Page:246—250 |
| 19. Comparison of modified Cherney incision and vertical midline incision for management of early stage cervical cancer. |
Page:246—250 |
| 20. Hypermethylation of E-cadherin in endometrial carcinoma. |
Page:241—245 |
| 21. Hypermethylation of E-cadherin in endometrial carcinoma. |
Page:241—245 |
| 22. Adjuvant therapy in high-risk early endometrial carcinoma: a retrospective analysis of 46 cases. |
Page:236—240 |
| 23. Adjuvant therapy in high-risk early endometrial carcinoma: a retrospective analysis of 46 cases. |
Page:236—240 |
| 24. The efficacy of sonographic morphology indexing and serum CA-125 for preoperative differentiation of malignant from benign ovarian tumors in patients after operation with ovarian tumors. |
Page:229—235 |
| 25. The efficacy of sonographic morphology indexing and serum CA-125 for preoperative differentiation of malignant from benign ovarian tumors in patients after operation with ovarian tumors. |
Page:229—235 |
| 26. Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer. |
Page:223—228 |
| 27. Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer. |
Page:223—228 |
| 28. Gynecologic oncology group trials in uterine corpus malignancies: recent progress. |
Page:218—222 |
| 29. Gynecologic oncology group trials in uterine corpus malignancies: recent progress. |
Page:218—222 |
| 30. Major clinical research advances in gynecologic cancer 2008. |
Page:209—217 |
| 31. Major clinical research advances in gynecologic cancer 2008. |
Page:209—217 |
| 32. Should we modify the current FIGO staging system for stage IIIC ovarian cancer?. |
Page:207—208 |
| 33. Should we modify the current FIGO staging system for stage IIIC ovarian cancer?. |
Page:207—208 |
